Shellie D Ellis1, Mugur Geana2, Christine B Mackay3, Deborah J Moon4, Jessie Gills5, Andrew Zganjar6, Gayle Brekke4, J Brantley Thrasher6, Tomas L Griebling7. 1. Department of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS; University of Kansas Cancer Center, Kansas City, KS. Electronic address: Sellis4@kumc.edu. 2. School of Journalism and Mass Communications, University of Kansas, Lawrence, KS; University of Kansas Cancer Center, Kansas City, KS. 3. Department of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS; University of Kansas Cancer Center, Kansas City, KS. 4. Department of Health Policy & Management, University of Kansas School of Medicine, Kansas City, KS. 5. Department of Urology, Louisiana State University, New Orleans, LA. 6. Department of Urology, University of Kansas School of Medicine, Kansas City, KS. 7. Department of Urology, University of Kansas School of Medicine, Kansas City, KS; The Landon Center on Aging, Kansas University Medical Center, Kansas City, KS.
Abstract
OBJECTIVE: Engaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities. We sought to identify determinants of referring patients to clinical trials among urology practices serving rural communities. METHODS: We conducted semistructured qualitative interviews based on the Theoretical Domains Framework at nonmetropolitan urology practices located in communities offering urological cancer trials. Participants were asked to consider barriers and strategies that might support engaging their patients in discussions about urological cancer clinical trials and referring them appropriately. Recorded interviews were transcribed and coded using template analysis. RESULTS: Most participants were not aware of available trials and had no experience with trial referral. Overall, participants held positive attitudes toward clinical trials and recognized their potential roles in accrual, but limited local resources reduced opportunities for offering trials. Most participants expressed a need for increased human, financial, and other resources to support this role. Many participants requested information and training to increase their knowledge of clinical trials and confidence in offering them to patients. Participants highlighted the need to build efficient pathways to identify available trials, match eligible patients, and facilitate communication and collaboration with cancer centers for patient follow-up and continuity of care. CONCLUSIONS: With adequate logistical and informational support, community urology practices could play an important role in clinical trial accrual, advancing cancer research and increasing treatment options for rural cancer patients. Future studies should explore the effectiveness of strategies to optimize urology practices' role in clinical trial accrual.
OBJECTIVE: Engaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities. We sought to identify determinants of referring patients to clinical trials among urology practices serving rural communities. METHODS: We conducted semistructured qualitative interviews based on the Theoretical Domains Framework at nonmetropolitan urology practices located in communities offering urological cancer trials. Participants were asked to consider barriers and strategies that might support engaging their patients in discussions about urological cancer clinical trials and referring them appropriately. Recorded interviews were transcribed and coded using template analysis. RESULTS: Most participants were not aware of available trials and had no experience with trial referral. Overall, participants held positive attitudes toward clinical trials and recognized their potential roles in accrual, but limited local resources reduced opportunities for offering trials. Most participants expressed a need for increased human, financial, and other resources to support this role. Many participants requested information and training to increase their knowledge of clinical trials and confidence in offering them to patients. Participants highlighted the need to build efficient pathways to identify available trials, match eligible patients, and facilitate communication and collaboration with cancer centers for patient follow-up and continuity of care. CONCLUSIONS: With adequate logistical and informational support, community urology practices could play an important role in clinical trial accrual, advancing cancer research and increasing treatment options for rural cancerpatients. Future studies should explore the effectiveness of strategies to optimize urology practices' role in clinical trial accrual.
Authors: Paul B Jacobsen; Kristen J Wells; Cathy D Meade; Gwendolyn P Quinn; Ji-Hyun Lee; William J Fulp; Jhanelle E Gray; Rachid C Baz; Gregory M Springett; Richard M Levine; Merry-Jennifer Markham; Fred J Schreiber; Thomas H Cartwright; James M Burke; Robert D Siegel; Mokenge P Malafa; Daniel Sullivan Journal: J Clin Oncol Date: 2012-05-21 Impact factor: 44.544
Authors: Warren B Sateren; Edward L Trimble; Jeffrey Abrams; Otis Brawley; Nancy Breen; Leslie Ford; Mary McCabe; Richard Kaplan; Malcolm Smith; Richard Ungerleider; Michaele C Christian Journal: J Clin Oncol Date: 2002-04-15 Impact factor: 44.544
Authors: Dana P Goldman; Sandra H Berry; Mary S McCabe; Meredith L Kilgore; Arnold L Potosky; Michael L Schoenbaum; Matthias Schonlau; Jane C Weeks; Richard Kaplan; Jose J Escarce Journal: JAMA Date: 2003-06-11 Impact factor: 56.272
Authors: Simon D French; Sally E Green; Denise A O'Connor; Joanne E McKenzie; Jill J Francis; Susan Michie; Rachelle Buchbinder; Peter Schattner; Neil Spike; Jeremy M Grimshaw Journal: Implement Sci Date: 2012-04-24 Impact factor: 7.327
Authors: Linda K Ko; Isabel C Scarinci; Elizabeth G Bouchard; Bettina F Drake; Elisa M Rodriguez; Moon S Chen; Deanna Kepka; Aaron J Kruse-Diehr; Christie Befort; Jackilen Shannon; Paige E Farris; Amy Trentham-Dietz; Tracy Onega Journal: JNCI Cancer Spectr Date: 2022-03-02
Authors: Shellie D Ellis; Riha Vaidya; Joseph M Unger; Kelly Stratton; Jessie Gills; Peter Van Veldhuizen; Eileen Mederos; Emily V Dressler; Matthew F Hudson; Charles Kamen; Heather B Neuman; Anne E Kazak; Ruth C Carlos; Kathryn E Weaver Journal: Contemp Clin Trials Commun Date: 2022-08-14